Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-11

FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron from JVET PHARMACEUTICALS LLC, enabling this generic product's expanded approval. The approval relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)